Adaptive Biotechnologies Corporation(NASDAQ:ADPT) 
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new progno...
Website: http://www.adaptivebiotech.com
Founded: 2009
IPO Price: $20 (Jun 27, 2019)
Full Time Employees: 453
CEO: Chad Robins
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.10
H 7.62
L 6.67
C 7.47
V 2,712,485
10EMA 7.47
20EMA 7.47
60EMA 7.47
120EMA 7.47
250EMA 7.47